Mylan Reacts to EpiPen Backlash – Wall Street Journal

Mylan Reacts to EpiPen Backlash
Wall Street Journal
Mylan MYL -0.70 % NV raced Thursday to counter a firestorm of criticism over its pricing of lifesaving EpiPens, saying it would help more patients cover their out-of-pocket costs. But the drugmaker didn't lower the list price, and its stranglehold on …
How Mylan, the maker of EpiPen, became a virtual monopolyWashington Post
'The system is broken' and EpiPens are just the tip of the icebergUSA TODAY
Mylan to Offer Some Patients Aid on Cost of EpiPensNew York Times
Fox News –Fortune –The Seattle Times –The Boston Globe
all 761 news articles »